DMK PHARMACEUTICALS Corp Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2022.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was -$44.7K, a 160% decline year-over-year.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was -$249K.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2022 was -$340K, a 117% decline from 2021.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2021 was $2.02M.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2012 was $36.8K, a 89.9% decline from 2011.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$340K -$2.36M -117% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $2.02M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2012 $36.8K -$328K -89.9% Apr 1, 2012 Mar 31, 2013 10-K 2013-07-03
2011 $365K Apr 1, 2011 Mar 31, 2012 10-K 2013-07-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.